-
21
-
22
-
23
Viral delivery of a peptide-based immunomodulator enhances T cell priming during vaccination
Published 2022-12-01Get full text
Article -
24
Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants
Published 2016-06-01Get full text
Article -
25
-
26
-
27
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain
Published 2021-11-01Get full text
Article -
28
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
Published 2023-11-01Get full text
Article -
29
-
30
From CD4-Based Initiation to Treating All HIV-Infected Adults Immediately: An Evidence-Based Meta-analysis
Published 2018-02-01Get full text
Article -
31
HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules
Published 2021-10-01Get full text
Article -
32
-
33
-
34
Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2
Published 2023-12-01Get full text
Article -
35
Impaired potency of neutralizing antibodies against cell–cell fusion mediated by SARS-CoV-2
Published 2023-12-01Get full text
Article -
36
Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2
Published 2018-08-01Get full text
Article -
37
Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo
Published 2018-09-01Get full text
Article -
38
-
39
-
40